Akso Research Development from 2010 to 2026
| AHG Stock | USD 1.47 0.05 3.52% |
Research Development | First Reported 2015-12-31 | Previous Quarter 112.6 K | Current Value 14.7 K | Quarterly Volatility 5.4 M |
Check Akso Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akso Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Selling General Administrative of 4 M or Selling And Marketing Expenses of 144 K, as well as many indicators such as Price To Sales Ratio of 30.39, Dividend Yield of 0.088 or PTB Ratio of 1.85. Akso financial statements analysis is a perfect complement when working with Akso Health Valuation or Volatility modules.
Akso | Research Development | Build AI portfolio with Akso Stock |
The Research Development trend for Akso Health Group offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Akso Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Akso Health's Research Development Growth Pattern
Below is the plot of the Research Development of Akso Health Group over the last few years. It is Akso Health's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Akso Health's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Akso Research Development Regression Statistics
| Arithmetic Mean | 3,451,202 | |
| Geometric Mean | 83,231 | |
| Coefficient Of Variation | 224.56 | |
| Mean Deviation | 4,189,815 | |
| Median | 1,605,636 | |
| Standard Deviation | 7,749,966 | |
| Sample Variance | 60.1T | |
| Range | 32.3M | |
| R-Value | (0.11) | |
| Mean Square Error | 63.3T | |
| R-Squared | 0.01 | |
| Significance | 0.67 | |
| Slope | (169,550) | |
| Total Sum of Squares | 961T |
Akso Research Development History
About Akso Health Financial Statements
Akso Health stakeholders use historical fundamental indicators, such as Akso Health's Research Development, to determine how well the company is positioned to perform in the future. Although Akso Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Akso Health's assets and liabilities are reflected in the revenues and expenses on Akso Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Akso Health Group. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 3.38 | 3.21 |
Currently Active Assets on Macroaxis
When determining whether Akso Health Group is a strong investment it is important to analyze Akso Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Akso Health's future performance. For an informed investment choice regarding Akso Stock, refer to the following important reports:Check out the analysis of Akso Health Correlation against competitors. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Akso have expansion opportunities? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Akso Health demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (0.48) | Revenue Per Share | Quarterly Revenue Growth 4.158 | Return On Assets | Return On Equity |
The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Akso Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Akso Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Akso Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.